Telotristat Ethyl (Xermelo)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Telotristat Ethyl (Xermelo), covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Telotristat Ethyl for the Treatment of Carcinoid Heart Disease in Patients With Metastatic Neuroendocrine Tumor [Phase 3]